Caixin
Caixin Global – Latest China News & Headlines

Home >

TRENDING
Zhipu Revenue Rises Nearly 400% as Cloud Business Gains Ground
Tencent Opens WorkBuddy Platform to Third Parties in Enterprise AI Push
Manus Resumes Independent Operations After Meta Deal Collapses
LATEST
Tencent Opens WorkBuddy Platform to Third Parties in Enterprise AI Push
Manus Resumes Independent Operations After Meta Deal Collapses
Zhipu Revenue Rises Nearly 400% as Cloud Business Gains Ground
Cover Story: How U.S. Tech Blockade Sparked China’s AI Chip Boom
Tencent Unveils Larger AI Model in Bid to Close Gap With Rivals
AI Chipmaker Sunrise Doubles Valuation After Raising 2 Billion Yuan
Analysis: Unitree Shares Slide as Investors Reassess Humanoid Robot Valuations
Baidu Shifts AI Agent Dumate Toward Industry-Specific Workflows
Z.AI Unveils Cheaper Model Running Entirely on Homegrown Chips
EHang Scraps Revenue Target in Wake of Fatal Aircraft Crash
XPeng to Raise $900 Million for Robotics Unit
China’s Advanced Chip Supply to Surge 46% Annually Through 2035, Goldman Says
Xiaomi Steps Up Chip Push With New Smartphone, AI and Self-Driving Processors
Alibaba’s $12 Billion Share Sale to Fund AI Push Sends Stock Lower
TikTok to Pay $400 Million to Settle U.S. Child Privacy Lawsuit
DeepSeek Enters the Multimodal AI Race with Experimental Vision Model
Alibaba’s Profit Plunges as E-Commerce Business Falters, AI Investment Jumps
YMTC Moves Closer to Shanghai IPO
Unitree Shares Decline as Founder Flags Limits of Humanoid Robots
AI Companies’ Success Lies in the Apps, Bain’s China Chairman Says

By Charlotte Yang / Dec 11, 2018 07:10 PM / Economy

Photo: VCG

Photo: VCG

Changsheng Bio-Technology, which in a high-profile scandal earlier this year was revealed to have fabricated data on its vaccines for infants, has received an advance notification of mandatory delisting from the Shenzhen Stock Exchange.

The exchange described the vaccine-maker's illegal activities as “seriously damaging to national interests and public interests.”

In a separate announcement, the company said the China Securities Regulatory Commission fined 17 related personnel for market violations, banned four from entering China’s stock markets for life, and three from entering the market for five years.

Related: Data-Faking Vaccine Firm to Be Kicked Off Stock Exchange Under New Rules


Share this article
Open WeChat and scan the QR code